HBC is delighted to announce the appointment of Paul Bruhn as Head of New Business Development. Mr Bruhn has over 25 years’ experience in healthcare and the medical nutrition space spanning Novartis Medical Nutrition and Nestlé Health Science.
He has been leading businesses across multiple geographies including Japan, Korea, India, the Middle East, Singapore, Canada, Switzerland, and Australia, and hence has an excellent overlap with corporates focused on developing the next generation of products targeting clinical nutrition and consumer healthcare.
Mr Bruhn has significant experience working within the medical nutrition, VMS, and meal replacement categories, across multiple channels.
Mr Bruhn says:
“I am delighted to contribute to the journey of taking HBC to the next level, particularly given the acceleration of business in Asia, China, and across the ANZ region. I believe there is a market need for new clinically backed sources of nutrition, and the specialty ingredients from Hofseth BioCare fill that gap.
HBC has developed a unique portfolio of bioactive ingredients called OmeGo®, ProGo®, NT-II™, and PetGo®, derived from salmon, which are backed by science and fully sustainable, ensuring that the whole salmon is utilized. For example, OmeGo®, unlike regular highly processed omega-3 fish oils, is a full-spectrum salmon oil containing all the omega fatty acids found in fresh whole fish. It is 100% natural and proven to be more absorbable, with clinical evidence to support anti-inflammation, heart health, and anti-allergy benefits. These ingredients will ensure differentiation in large product categories that are craving innovation. I look forward to helping put them into leading brands.”